Market Tracker

10/20 5:16pm ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

9.25
Delayed Data
As of Oct 20
 +0.47 / +5.35%
Today’s Change
8.16
Today|||52-Week Range
14.22
-11.57%
Year-to-Date

Today’s Trading

Previous close8.78
Today’s open9.49
Day’s range9.00 - 9.59
Volume219,837
Average volume (3 months)99,004
Market cap$158.9M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-21.48%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,278.54%
P/E ratio--
Price/Sales1,329.82
Price/Book2.44

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...+0.25+14.29%
REPHRecro Pharma Inc+0.02+0.22%
TRVNTrevena Inc+0.10+6.02%
VCELVericel Corp-0.30-6.67%
Data as of 4:00pm ET, 10/20/2017

Financials

Next reporting dateNovember 13, 2017
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$101.3K
Annual profit (last year)-$29.5M
Net profit margin-29,079.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts